BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
C. M. Annunziata, N. Azad, A. S. Dhamoon, G. Whiteley, E. C. Kohn. Ovarian cancer in the proteomics eraInternational Journal of Gynecologic Cancer 2008; 18(Suppl 1): 1 doi: 10.1111/j.1525-1438.2007.01096.x
2
Wataru Kikuchi, Motoi Nishimura, Takahisa Kuga, Sachio Tsuchida, Tatsuya Saito, Mamoru Satoh, Kenta Noda, Yoshio Kodera, Takeshi Tomonaga, Fumio Nomura. Fibrinogen alpha C chain 5.9 kDa fragment (FIC5.9), a biomarker for various pathological conditions, is produced in post-blood collection by fibrinolysis and coagulation factorsClinical Proteomics 2016; 13(1) doi: 10.1186/s12014-016-9129-6
3
Current literature in mass spectrometryJournal of Mass Spectrometry 2007; 42(4): 547 doi: 10.1002/jms.1073
4
Marie-Christine W Gast, Judith YMN Engwegen, Jan HM Schellens, Jos H Beijnen. Comparing the old and new generation SELDI-TOF MS: implications for serum protein profilingBMC Medical Genomics 2008; 1(1) doi: 10.1186/1755-8794-1-4
5
Kewal K. Jain. Innovations, challenges and future prospects of oncoproteomicsMolecular Oncology 2008; 2(2): 153 doi: 10.1016/j.molonc.2008.05.003
6
Masaki Shibayama, Matthias Maak, Ulrich Nitsche, Kengo Gotoh, Robert Rosenberg, Klaus-Peter Janssen. Prediction of Metastasis and Recurrence in Colorectal Cancer Based on Gene Expression Analysis: Ready for the Clinic?Cancers 2011; 3(3): 2858 doi: 10.3390/cancers3032858
7
J. Holcakova, L. Hernychova, P. Bouchal, K. Brozkova, J. Zaloudik, D. Valik, R. Nenutil, B. Vojtesek. Identification of αB-Crystallin, a Biomarker of Renal Cell Carcinoma by SELDI-TOF MSThe International Journal of Biological Markers 2008; 23(1): 48 doi: 10.1177/172460080802300108
8
L. C. Whelan, K. A. R. Power, D. T. McDowell, J. Kennedy, W. M. Gallagher. Applications of SELDI-MS technology in oncologyJournal of Cellular and Molecular Medicine 2008; 12(5a): 1535 doi: 10.1111/j.1582-4934.2008.00250.x
9
Peter Findeisen, Michael Neumaier. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspectiveClinical Chemistry and Laboratory Medicine 2009; 47(6) doi: 10.1515/CCLM.2009.159
10
Feng Jiang, Xiang-Yu Zhou, Jing Huang. The Value of Surface Enhanced Laser Desorption/Ionization-Time of Flight Mass Spectrometry at the Diagnosis of Non-Small Cell Lung Cancer: A Systematic ReviewTechnology in Cancer Research & Treatment 2014; 13(2): 109 doi: 10.7785/tcrt.2012.500360
11
Marie-Christine W. Gast, Eric J. van Dulken, Thea K.G. van Loenen, Florine Kingma-Vegter, Johan Westerga, Claudie C. Flohil, Jaco C. Knol, Connie R. Jimenez, Carla H. van Gils, Lodewijk F.A. Wessels, Jan H.M. Schellens, Jos H. Beijnen. Detection of Breast Cancer by Surface-enhanced Laser Desorption/Ionization Time-of-flight Mass Spectrometry Tissue and Serum Protein ProfilingThe International Journal of Biological Markers 2009; 24(3): 130 doi: 10.1177/172460080902400302
12
Junjie Zhang, Fei Guo, Lei Wang, Wei Zhao, Da Zhang, Heying Yang, Jiekai Yu, Lili Niu, Fuquan Yang, Shu Zheng, Jiaxiang Wang. Identification of Apolipoprotein C-I as a Potential Wilms’ Tumor Marker after Excluding Inflammatory FactorsInternational Journal of Molecular Sciences 2014; 15(9): 16186 doi: 10.3390/ijms150916186
13
A. A. Terentiev, N. T. Moldogazieva, K. V. Shaitan. Dynamic proteomics in modeling of the living cell. Protein-protein interactionsBiochemistry (Moscow) 2009; 74(13): 1586 doi: 10.1134/S0006297909130112
14
Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancerPROTEOMICS - Clinical Applications 2012; 6(3-4): 182 doi: 10.1002/prca.201100095
15
Mary E. Ziegler, Tingchao Chen, James F. LeBlanc, Xuelian Wei, David W. Gjertson, Ker-Chau Li, Mazdak A. Khalighi, Charles R. Lassman, Jeffrey L. Veale, H. Albin Gritsch, Elaine F. Reed. Apolipoprotein A1 and C-Terminal Fragment of α-1 Antichymotrypsin Are Candidate Plasma Biomarkers Associated With Acute Renal Allograft RejectionTransplantation 2011; 92(4): 388 doi: 10.1097/TP.0b013e318225db6a
16
Judith Y.M.N. Engwegen, Marie-Christine W. Gast, Jan H.M. Schellens, Jos H. Beijnen. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometryTrends in Pharmacological Sciences 2006; 27(5): 251 doi: 10.1016/j.tips.2006.03.003
17
Marie-Christine W. Gast, Carla H. van Gils, Lodewijk F.A. Wessels, Nathan Harris, Johannes M.G. Bonfrer, Emiel J.Th. Rutgers, Jan H.M. Schellens, Jos H. Beijnen. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS)Clinical Chemistry and Laboratory Medicine 2009; 47(6) doi: 10.1515/CCLM.2009.151
18
Thomas Göbel, Sonja Vorderwülbecke, Katarzyna Hauck, Holger Fey, Dieter Häussinger, Andreas Erhardt. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samplesWorld Journal of Gastroenterology 2006; 12(47): 7604-7612 doi: 10.3748/wjg.v12.i47.7604
19
ME de Noo, RAEM Tollenaar, AM Deelder, LH Bouwman. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: Hopes and fearsWorld Journal of Gastroenterology 2006; 12(41): 6594-6601 doi: 10.3748/wjg.v12.i41.6594
20
John F Timms, Elif Arslan-Low, Aleksandra Gentry-Maharaj, Zhiyuan Luo, Davy T’Jampens, Vladimir N Podust, Jeremy Ford, Eric T Fung, Alex Gammerman, Ian Jacobs, Usha Menon. Preanalytic Influence of Sample Handling on SELDI-TOF Serum Protein ProfilesClinical Chemistry 2007; 53(4): 645 doi: 10.1373/clinchem.2006.080101
21
Chafika Mazouni, Keith Baggerly, David Hawke, Spyros Tsavachidis, Fabrice André, Aman U. Buzdar, Pierre-Marie Martin, Ryuji Kobayashi, Lajos Pusztai. Evaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2-positive breast cancer using an LC-MALDI-TOF/MS procedurePROTEOMICS 2010; 10(19): 3525 doi: 10.1002/pmic.201000057
22
Ming Lu, Kym F. Faull, Julian P. Whitelegge, Jianbo He, Dejun Shen, Romaine E. Saxton, Helena R. Chang. Proteomics and Mass Spectrometry for Cancer Biomarker DiscoveryBiomarker Insights 2007; 2: 117727190700200 doi: 10.1177/117727190700200005
23
Yun Liu, Fangqiao Wei, Feng Wang, Changdong Li, Ge Meng, Hua Duan, Qingwei Ma, Weiyuan Zhang. Serum peptidome profiling analysis for the identification of potential biomarkers in cervical intraepithelial neoplasia patientsBiochemical and Biophysical Research Communications 2015; 465(3): 476 doi: 10.1016/j.bbrc.2015.08.042
24
Santiago Marfà, Wladimiro Jimenez. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 493 doi: 10.1007/978-94-007-7675-3_7
25
Ashraf G. Madian, Nishi S. Rochelle, Fred E. Regnier. Mass-Linked Immuno-Selective Assays in Targeted ProteomicsAnalytical Chemistry 2013; 85(2): 737 doi: 10.1021/ac302071k
26
Hao Wang, Chenghua Luo, Shengtao Zhu, Honghong Fang, Qing Gao, Siqi Ge, Haixia Qu, Qingwei Ma, Hongwei Ren, Youxin Wang, Wei Wang. Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohortsOncotarget 2017; 8(35): 59376 doi: 10.18632/oncotarget.19587
27
HELGI H. HELGASON, JUDITH Y.M.N. ENGWEGEN, MARK ZAPATKA, ANNEMIEKE CATS, HENK BOOT, JOS H. BEIJNEN, JAN H.M. SCHELLENS. Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancerOncology Letters 2010; 1(2): 327 doi: 10.3892/ol_00000058
28
Annemieke W.J. Opstal-van Winden, Jos H. Beijnen, Arnoud Loof, Waander L. van Heerde, Roel Vermeulen, Petra H.M. Peeters, Carla H. van Gils. Search for Breast Cancer Biomarkers in Fractionated Serum Samples by Protein Profiling With SELDI-TOF MSJournal of Clinical Laboratory Analysis 2012; 26(1): 1 doi: 10.1002/jcla.20492
29
Kenta Noda, Kazuyuki Sogawa, Wataru Kikuchi, Iwao Kiyokawa, Toshihide Miura, Ryo Kojima, Katsuhiro Katayama, Yoshio Kodera, Fumio Nomura. Development of a sandwich ELISA for the 5.9-kDa fibrinogen alpha C chain fragment detected by serum proteome analysisPROTEOMICS - Clinical Applications 2011; 5(3-4): 141 doi: 10.1002/prca.201000127
30
Nicola Marchi, Peter Mazzone, Vincent Fazio, Tarek Mekhail, Thomas Masaryk, Damir Janigro. ProApolipoprotein A1Cancer 2008; 112(6): 1313 doi: 10.1002/cncr.23314
31
CHIBO LIU, CHUNQIN PAN, YONG LIANG. Screening and identification of serum proteomic biomarkers for gastric adenocarcinomaExperimental and Therapeutic Medicine 2012; 3(6): 1005 doi: 10.3892/etm.2012.515
32
Ye-Sheng Wei, Yan-Hua Zheng, Wei-Bo Liang, Jian-Zhong Zhang, Zhi-Hui Yang, Mei-Li Lv, Jing Jia, Lin Zhang. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysisCancer 2008; 112(3): 544 doi: 10.1002/cncr.23204
33
Q.-Y. Hu, J. Su, H. Jiang, L.-L. Wang, Y.-Q. Jia. Potential role of proteomics in the diagnosis of lymphoma: a meta-analysisInternational Journal of Laboratory Hematology 2013; 35(4): 367 doi: 10.1111/ijlh.12032
34
Magnus Palmblad, Ali Tiss, Rainer Cramer. Mass spectrometry in clinical proteomics - from the present to the futurePROTEOMICS - CLINICAL APPLICATIONS 2009; 3(1): 6 doi: 10.1002/prca.200800090
35
Annemieke W. J. Opstal-van Winden, Roel C. H. Vermeulen, Petra H. M. Peeters, Jos H. Beijnen, Carla H. van Gils. Early diagnostic protein biomarkers for breast cancer: how far have we come?Breast Cancer Research and Treatment 2012; 134(1): 1 doi: 10.1007/s10549-011-1907-2
36
Andrew Rundle, Habibul Ahsan, Paolo Vineis. Better cancer biomarker discovery through better study designEuropean Journal of Clinical Investigation 2012; 42(12): 1350 doi: 10.1111/j.1365-2362.2012.02727.x
37
Anna Bodzon-Kulakowska, Anna Bierczynska-Krzysik, Tomasz Dylag, Anna Drabik, Piotr Suder, Marek Noga, Justyna Jarzebinska, Jerzy Silberring. Methods for samples preparation in proteomic researchJournal of Chromatography B 2007; 849(1-2): 1 doi: 10.1016/j.jchromb.2006.10.040
38
Hu Qiong-ying, Kai-zheng Wang, Yin-huan Ding, Lv-fang Zheng, Shuang-hua Liang, Zheng-ming Lei, Wen-guang Fu, Li Yan. Application of SELDI-TOF-MS Coupled With an Artificial Neural Network Model to the Diagnosis of Pancreatic CancerLaboratory Medicine 2010; 41(11): 676 doi: 10.1309/LMH6TUOMQKX6V2DN
39
Jose L. Luque-Garcia, Thomas A. Neubert. Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometryJournal of Chromatography A 2007; 1153(1-2): 259 doi: 10.1016/j.chroma.2006.11.054
40
Gary L. Nelsestuen, Stephen B. Harvey, Yan Zhang, Raj S. Kasthuri, Alan R. Sinaiko, E. Wesley Ely, Gordon R. Bernard, Monika Homoncik, Bernd Jilma. Top-down proteomic analysis by MALDI-TOF profiling: Concentration-independent biomarkersPROTEOMICS – CLINICAL APPLICATIONS 2008; 2(2): 158 doi: 10.1002/prca.200780107
41
Ilaria Chiodi, A. Ivana Scovassi, Chiara Mondello. Translational Toxicology and Therapeutics: Windows of Developmental Susceptibility in Reproduction and Cancer2017; : 607 doi: 10.1002/9781119023647.ch16
42
Wei-peng Su, Li-na Sun, Shun-liang Yang, Hu Zhao, Teng-yue Zeng, Wei-zhen Wu, Dong Wang. Apolipoprotein C1 promotes prostate cancer cell proliferation in vitroJournal of Biochemical and Molecular Toxicology 2018; 32(7): e22158 doi: 10.1002/jbt.22158
43
P Kelly, V Appleyard, K Murray, F Paulin, D Lamont, L Baker, S Suttie, D Exon, A Thompson. Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapyBritish Journal of Cancer 2010; 103(2): 232 doi: 10.1038/sj.bjc.6605741
44
Lay Cheng Lim, Mee Lee Looi, Syed Zulkifli Syed Zakaria, Ismail Sagap, Isa Mohammed Rose, Siok-Fong Chin, Rahman Jamal. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics AnalysisPathology & Oncology Research 2016; 22(1): 169 doi: 10.1007/s12253-015-9991-y
45
Jung-Won Choi, Hao Liu, Dong Hoon Shin, Gyeong Im Yu, Jae Seok Hwang, Eun Soo Kim, Jong Won Yun. Proteomic and cytokine plasma biomarkers for predicting progression from colorectal adenoma to carcinoma in human patientsPROTEOMICS 2013; 13(15): 2361 doi: 10.1002/pmic.201200550
46
Sanket P. Borgaonkar, Harrison Hocker, Hyunjin Shin, Mia K. Markey. Comparison of Normalization Methods for the Identification of Biomarkers Using MALDI-TOF and SELDI-TOF Mass SpectraOMICS: A Journal of Integrative Biology 2010; 14(1): 115 doi: 10.1089/omi.2009.0082
47
Petra Hudler, Nina Kocevar, Radovan Komel. Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer DiagnosticsThe Scientific World Journal 2014; 2014: 1 doi: 10.1155/2014/260348
48
Michael C.J. Quinn, Abdelali Filali-Mouhim, Diane M. Provencher, Anne-Marie Mes-Masson, Patricia N. Tonin. Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancerMolecular Carcinogenesis 2009; 48(7): 648 doi: 10.1002/mc.20511
49
José Manuel González-Buitrago, Laura Ferreira, María Del Carmen Muñiz. Proteómica clínica y nuevos biomarcadores en los líquidos biológicosMedicina Clínica 2008; 131(11): 426 doi: 10.1157/13126219
50
Seamus M McHugh, Jill O'Donnell, Peter Gillen. Genomic and oncoproteomic advances in detection and treatment of colorectal cancerWorld Journal of Surgical Oncology 2009; 7(1) doi: 10.1186/1477-7819-7-36
51
Mamoun Ahram, Emanuel F. Petricoin. Proteomics Discovery of Disease BiomarkersBiomarker Insights 2008; 3: BMI.S689 doi: 10.4137/BMI.S689
52
Biomarker Signature Discovery from Mass Spectrometry DataIEEE/ACM Transactions on Computational Biology and Bioinformatics 2014; 11(4): 766 doi: 10.1109/TCBB.2014.2318718
53
Päivi Sirniö, Juha P. Väyrynen, Kai Klintrup, Jyrki Mäkelä, Markus J. Mäkinen, Tuomo J. Karttunen, Anne Tuomisto. Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancerScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-05415-9
54
Sergio Ciordia, Vivian de los Ríos, Juan-Pablo Albar. Contributions of advanced proteomics technologies to cancer diagnosisClinical and Translational Oncology 2006; 8(8): 566 doi: 10.1007/s12094-006-0062-4
55
Desta Kassa, Leonie Ran, Wilco de Jager, Theo van den Broek, Ronald Jacobi, Muluberhan Mekonen, Tsehaynesh Messele, Mariëlle C. Haks, Tom H.M. Ottenhoff, Debbie van Baarle. Discriminative expression of whole blood genes in HIV patients with latent and active TB in EthiopiaTuberculosis 2016; 100: 25 doi: 10.1016/j.tube.2016.06.003
56
Kaori Yamamoto-Ishikawa, Hiroyoshi Suzuki, Masahiko Nezu, Naoto Kamiya, Takashi Imamoto, Akira Komiya, Kazuyuki Sogawa, Takeshi Tomonaga, Fumio Nomura, Tomohiko Ichikawa. The isolation and identification of apolipoprotein C-I in hormone-refractory prostate cancer using surface-enhanced laser desorption/ionization time-of-flight mass spectrometryAsian Journal of Andrology 2009; 11(3): 299 doi: 10.1038/aja.2008.38
57
Matilda Holm, Sakari Joenväärä, Mayank Saraswat, Tiialotta Tohmola, Ari Ristimäki, Risto Renkonen, Caj Haglund. Differences and overlap in plasma protein expression during colorectal cancer progressionTranslational Medicine Communications 2019; 4(1) doi: 10.1186/s41231-019-0044-5
58
Judith YMN Derijks-Engwegen, Annemieke Cats, Marianne E Smits, Jan HM Schellens, Jos H Beijnen. Improving colorectal cancer management: the potential of proteomicsBiomarkers in Medicine 2008; 2(3): 253 doi: 10.2217/17520363.2.3.253
59
Annemieke WJ Opstal-van Winden, Esmeralda JM Krop, Monica H Kåredal, Marie-Christine W Gast, Christian H Lindh, Marina C Jeppsson, Bo AG Jönsson, Diederick E Grobbee, Petra HM Peeters, Jos H Beijnen, Carla H van Gils, Roel CH Vermeulen. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control studyBMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-381
60
Yanying Wang, Gaoguang Song, Yanmin Wang, Ling Qiu, Xuzhen Qin, Hui Liu, Fang Li, Xiaodong Wang, Fenjie Li, Shuai Guo, Yaping Zhang, Zhili Li. Elevated Serum Levels of Circulating Immunoinflammation-Related Protein Complexes Are Associated with CancerJournal of Proteome Research 2014; 13(2): 710 doi: 10.1021/pr4008255
61
Judith Y.M.N. Engwegen, Annekatrien C.T.M. Depla, Marianne E. Smits, Annemieke Cats, Henriëtte Tuynman, Henk A. Van Heukelem, Pleun Snel, Wouter Meuleman, Lodewyk F. Wessels, Jan H.M. Schellens, Jos H. Beijnen. Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at RiskBiomarker Insights 2008; 3: BMI.S790 doi: 10.4137/BMI.S790
62
Francesca Maffei, Sabrina Angelini, Giorgio Cantelli Forti, Patrizia Hrelia. Blood Biomarkers Linked to Oxidative Stress and Chronic Inflammation for Risk Assessment of Colorectal NeoplasiaCurrent Colorectal Cancer Reports 2013; 9(1): 85 doi: 10.1007/s11888-012-0156-z
63
Weigui Sun, Zhangqun Ye, Zhenguo Mi, Tianliang Shi, Cunzhi Han, Sutang Guo. A comparative study on proteomics between LNCap and DU145 cells by quantitative detection and SELDI analysisJournal of Huazhong University of Science and Technology [Medical Sciences] 2008; 28(2): 174 doi: 10.1007/s11596-008-0215-5
64
Paul Dowling, Lorraine O'Driscoll, Paula Meleady, Michael Henry, Shunil Roy, Jo Ballot, Michael Moriarty, John Crown, Martin Clynes. 2-D difference gel electrophoresis of the lung squamous cell carcinomaversus normal sera demonstrates consistent alterations in the levels of ten specific proteinsELECTROPHORESIS 2007; 28(23): 4302 doi: 10.1002/elps.200700246
65
L. Lo Russo, M. Papale, D. Perrone, E. Ranieri, C. Rubini, G. Giannatempo, A. Santarelli, G. Colella, L. Lo Muzio. Salivary Proteomic Signatures of Oral Squamous Cell CarcinomaEuropean Journal of Inflammation 2012; 10(1): 61 doi: 10.1177/1721727X1201000107
66
Kewal K. Jain. Applications of Biotechnology in Oncology2014; : 63 doi: 10.1007/978-1-4614-9245-0_4
67
Jianwei Zhang, Yue Cai, Huabin Hu, Ping Lan, Lei Wang, Meijin Huang, Liang Kang, Xiaojian Wu, Hui Wang, Jiayu Ling, Jian Xiao, Jianping Wang, Yanhong Deng. Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC studyOncotarget 2016; 7(4): 5053 doi: 10.18632/oncotarget.6469
68
Jakob Albrethsen, Anne Kaas, Eugen Schönle, Peter Swift, Mirjana Kocova, Steen Gammeltoft, Lars Hansen, Henrik Bindesbøl Mortensen. Evaluation of a type 1 diabetes serum cohort by SELDI-TOF MS protein profilingPROTEOMICS - CLINICAL APPLICATIONS 2009; 3(3): 383 doi: 10.1002/prca.200800063
69
Kazuyuki Sogawa, Kenta Noda, Hiroshi Umemura, Masanori Seimiya, Takahisa Kuga, Takeshi Tomonaga, Motoi Nishimura, Fumihiko Kanai, Fumio Imazeki, Hirotaka Takizawa, Masato Yoneda, Atsushi Nakajima, Mikihiro Tsutsumi, Osamu Yokosuka, Fumio Nomura. Serum fibrinogen alpha C-chain 5.9 kDa fragment as a biomarker for early detection of hepatic fibrosis related to hepatitis C virusPROTEOMICS - Clinical Applications 2013; 7(5-6): 424 doi: 10.1002/prca.201200094
70
Michela Bertuzzi, Cristina Marelli, Renzo Bagnati, Alessandro Colombi, Roberto Fanelli, Calogero Saieva, Marco Ceroti, Benedetta Bendinelli, Saverio Caini, Luisa Airoldi, Domenico Palli. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot studyBMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1058-7
71
Chandrika J. Piyathilake, Denise K. Oelschlager, Sreelatha Meleth, Edward E. Partridge, William E. Grizzle. Plasma Protein Profiles Differ between Women Diagnosed with Cervical Intraepithelial Neoplasia (CIN) 1 and 3Cancer Informatics 2006; 2: 117693510600200 doi: 10.1177/117693510600200026
72
Nikhil Pawa, Tan Arulampalam, John D. Norton. Screening for colorectal cancer: established and emerging modalitiesNature Reviews Gastroenterology & Hepatology 2011; 8(12): 711 doi: 10.1038/nrgastro.2011.205
73
Wouter Meuleman, Judith YMN Engwegen, Marie-Christine W Gast, Jos H Beijnen, Marcel JT Reinders, Lodewyk FA Wessels. Comparison of normalisation methods for surface-enhanced laser desorption and ionisation (SELDI) time-of-flight (TOF) mass spectrometry dataBMC Bioinformatics 2008; 9(1) doi: 10.1186/1471-2105-9-88
74
M Hepponstall, V Ignjatovic, S Binos, C Attard, V Karlaftis, Y d’Udekem, P Monagle, I E Konstantinov. Cardiopulmonary bypass changes the plasma proteome in children undergoing tetralogy of Fallot repairPerfusion 2015; 30(7): 556 doi: 10.1177/0267659114566065
75
Santiago Marfà, Wladimiro Jimenez. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_7-1
76
Anouck Huijbers, Berit Velstra, Tim J. A. Dekker, Wilma E. Mesker, Yuri E. M. van der Burgt, Bart J. Mertens, André M. Deelder, Rob A. E. M. Tollenaar. Proteomic Serum Biomarkers and Their Potential Application in Cancer Screening ProgramsInternational Journal of Molecular Sciences 2010; 11(11): 4175 doi: 10.3390/ijms11114175
77
Hui Chen, Zan Lin, Lin Mo, Chao Tan. Identification of Colorectal Cancer Using Near-Infrared Spectroscopy and Adaboost with Decision StumpAnalytical Letters 2017; 50(16): 2608 doi: 10.1080/00032719.2017.1310880
78
Gabriel D. Dakubo. Cancer Biomarkers in Body Fluids2017; : 213 doi: 10.1007/978-3-319-48360-3_7
79
Amir M. Sheikh, Cindy Barrett, Nestor Villamizar, Oscar Alzate, Sara Miller, John Shelburne, Andrew Lodge, Jeffrey Lawson, James Jaggers. Proteomics of cerebral injury in a neonatal model of cardiopulmonary bypass with deep hypothermic circulatory arrestThe Journal of Thoracic and Cardiovascular Surgery 2006; 132(4): 820 doi: 10.1016/j.jtcvs.2006.07.002
80
Matilda Holm, Sakari Joenväärä, Mayank Saraswat, Harri Mustonen, Tiialotta Tohmola, Ari Ristimäki, Risto Renkonen, Caj Haglund. Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcomeFASEB BioAdvances 2019; 1(12): 723 doi: 10.1096/fba.2019-00062
81
Sofiya Kolusheva, Rami Yossef, Aleksandra Kugel, Nirit Hanin-Avraham, Meital Cohen, Eitan Rubin, Angel Porgador. A Novel “Reactomics” Approach for Cancer DiagnosticsSensors 2012; 12(5): 5572 doi: 10.3390/s120505572
82
Judith Y. M. N. Engwegen, Marieke Alberts, Jaco C. Knol, Connie R. Jimenez, Annekatrien C. T. M. Depla, Henriëtte Tuynman, Henk A. van Heukelem, Pleun Snel, Marianne E. Smits, Annemieke Cats, Jan H. M. Schellens, Jos H. Beijnen. Influence of variations in sample handling on SELDI-TOF MS serum protein profiles for colorectal cancerPROTEOMICS – CLINICAL APPLICATIONS 2008; 2(6): 936 doi: 10.1002/prca.200780068
83
N. Deckers, P. Dorny, K. Kanobana, J. Vercruysse, A.E. Gonzalez, B. Ward, M. Ndao. Use of ProteinChip technology for identifying biomarkers of parasitic diseases: The example of porcine cysticercosis (Taenia solium)Experimental Parasitology 2008; 120(4): 320 doi: 10.1016/j.exppara.2008.08.013
84
Michael T. Davis, Paul Auger, Chris Spahr, Scott D. Patterson. Cancer biomarker discoveryvia low molecular weight serum proteome profiling – Where is the tumor?PROTEOMICS – CLINICAL APPLICATIONS 2007; 1(12): 1545 doi: 10.1002/prca.200700141
85
Konstantinos K. Tsilidis, Casey Branchini, Eliseo Guallar, Kathy J. Helzlsouer, Thomas P. Erlinger, Elizabeth A. Platz. C‐reactive protein and colorectal cancer risk: A systematic review of prospective studiesInternational Journal of Cancer 2008; 123(5): 1133 doi: 10.1002/ijc.23606
86
Hannah Bateson, Saira Saleem, Paul M. Loadman, Chris W. Sutton. Use of matrix-assisted laser desorption/ionisation mass spectrometry in cancer researchJournal of Pharmacological and Toxicological Methods 2011; 64(3): 197 doi: 10.1016/j.vascn.2011.04.003
87
Hui Chen, Zan Lin, Lin Mo, Tong Wu, Chao Tan. Near-Infrared Spectroscopy as a Diagnostic Tool for Distinguishing between Normal and Malignant Colorectal TissuesBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/472197
88
Valeria R. Mas, Daniel G. Maluf, Kellie J. Archer, Kenneth Yanek, Karen Bornstein, Robert A. Fisher. Proteomic Analysis of HCV Cirrhosis and HCV-Induced HCC: Identifying Biomarkers for Monitoring HCV-Cirrhotic Patients Awaiting Liver TransplantationTransplantation 2009; 87(1): 143 doi: 10.1097/TP.0b013e318191c68d
89
Dongjian Song, Lifang Yue, Hao Li, Junjie Zhang, Zechen Yan, Yingzhong Fan, Heying Yang, Qiuliang Liu, Da Zhang, Ziqiang Xia, Pan Qin, Jia Jia, Ming Yue, Jiekai Yu, Shu Zheng, Fuquan Yang, Jiaxiang Wang. Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometryBritish Journal of Cancer 2016; 114(8): 929 doi: 10.1038/bjc.2016.52
90
N. A. Pakharukova, L. Kh. Pastushkova, S. A. Moshkovskii, I. M. Larina. Variability of the healthy human proteomeBiochemistry (Moscow) Supplement Series B: Biomedical Chemistry 2011; 5(3): 203 doi: 10.1134/S1990750811030097
91
Timo Gemoll, Uwe Johannes Roblick, Gert Auer, Hans Jörnvall, Jens Karsten Habermann. SELDI-TOF serum proteomics and colorectal cancer: A current overviewArchives of Physiology and Biochemistry 2010; 116(4-5): 188 doi: 10.3109/13813455.2010.495130
92
Ying Lin, William S. Dynan, Jeffrey R. Lee, Zhao-Hua Zhu, Robert R. Schade. The Current State of Proteomics in GI OncologyDigestive Diseases and Sciences 2009; 54(3): 431 doi: 10.1007/s10620-008-0656-5
93
Joost P.J.J. Hegmans, Joris D. Veltman, Eric T. Fung, Thorsten Verch, Curtis Glover, Fujun Zhang, W. Jeffrey Allard, Davy T'Jampens, Henk C. Hoogsteden, Bart N. Lambrecht, Joachim Aerts. Protein Profiling of Pleural Effusions to Identify Malignant Pleural Mesothelioma Using SELDI-TOF MSTechnology in Cancer Research & Treatment 2009; 8(5): 323 doi: 10.1177/153303460900800502
94
Claudia Martelli, Federica Iavarone, Federica Vincenzoni, Diana Valeria Rossetti, Luca D'Angelo, Gianpiero Tamburrini, Massimo Caldarelli, Concezio Di Rocco, Irene Messana, Massimo Castagnola, Claudia Desiderio. Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approachesELECTROPHORESIS 2014; : n/a doi: 10.1002/elps.201300578
95
Meital Cohen, Rami Yossef, Tamir Erez, Aleksandra Kugel, Michael Welt, Mark M. Karpasas, Jonathan Bones, Pauline M. Rudd, Julien Taieb, Herve Boissin, Dror Harats, Karin Noy, Yoram Tekoah, Rachel G. Lichtenstein, Eitan Rubin, Angel Porgador, Hana Algül. Serum Apolipoproteins C-I and C-III Are Reduced in Stomach Cancer Patients: Results from MALDI-Based Peptidome and Immuno-Based Clinical AssaysPLoS ONE 2011; 6(1): e14540 doi: 10.1371/journal.pone.0014540
96
M.A. Karpova, S.A. Moshkovskii, I.Y. Toropygin, A.I. Archakov. Cancer-specific MALDI-TOF profiles of blood serum and plasma: Biological meaning and perspectivesJournal of Proteomics 2010; 73(3): 537 doi: 10.1016/j.jprot.2009.09.011
97
Ming Zhi Zhang, Zhen Chang Sun, Xiao Rui Fu, Fei Fei Nan, Qing Xia Fan, Xing Ai Wu, Li Geng, Wang Ma, Rui Lin Wang. Analysis of serum proteome profiles of non-Hodgkin lymphoma for biomarker identificationJournal of Proteomics 2009; 72(6): 952 doi: 10.1016/j.jprot.2009.03.009
98
Hui Chen, Zan Lin, Chao Tan. Probabilistic Characterization Using Partial Least Squares and Near-Infrared Spectroscopy for Cancer DiagnosisAnalytical Letters 2015; 48(14): 2234 doi: 10.1080/00032719.2015.1027900
99
Anne K. Callesen, Ole Mogensen, Andreas K. Jensen, Torben A. Kruse, Torben Martinussen, Ole N. Jensen, Jonna S. Madsen. Reproducibility of mass spectrometry based protein profiles for diagnosis of ovarian cancer across clinical studies: A systematic reviewJournal of Proteomics 2012; 75(10): 2758 doi: 10.1016/j.jprot.2012.02.007